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Summary: IgG antibodies against antigens
of various mycobacteria were estimated by
ELISA in serum samples collected (a) from
36 children (mean age 4.4 years) belonging
to Koppur village in the south Indian BCG
Tr ia l  a rea ,  (b )  before  and a f ter  BCG
vaccination of 13 young individuals (mean
age 16.5 years) belonging to Trivellore in
the same area and (c) before and after BCG
vaccination from 20 young British subjects
(mean age 14.5  years) .  In  the  Koppur
children, the antibody levels were highest
against M. scrofulaceum and M. avium and
lowest against M. bovis and M. tuberculosis
H37Rv. In these children, there was no
correlation between antibody levels and
tuberculin reactivity. In the Trivellore
subjects, antibody levels were highest against
M. bovis BCG and M. gordonae, and lowest
against PPD RT22 and M. terrae and none
of the differences in the antibody levels
against individual antigens between the pre-
and post-BCG serum samples was statistically
Significant (p >.05). The British subjects had
the highest levels against M. tuberculosis
7219 while the lowest levels were against
M. kansasii and M. tuberculosis 51; after BCG
vacc ina t i on  t he  an t i body  l eve l s  we re
selectively increased against M. tuberculosis
7219, M. flavescens and M. gordornae (p <0.05).
Introduction
The protective effect of BCG in controlled
trials has ranged from none in a  south Indian trial
to almost 80 per cent in a British trial1. It is likely
that the low protective effect in south India
compared to Britain is at least partly due to
greater prior sensitisation to environmental
mycobacreria in south India which may obviate
or block the effect of subsequent vaccination.2-4
The degree of sensitization to mycobacterial
antigens varies from country to country probably
because of the relative prevalences of non-
tuberculous mycobacteria (NTM) in the
environment and genetic factors, or even within
the same area due to differences in age and social
behaviour patterns5. Presumably, in south India
there is a widespread infection with NTM in
children from very early age, and it has been
reported that among the NTM, M.avium
intracellulare, M. terrae and M.scrofulaceum are
the species most frequently isolated from the
sputum of subjects belonging to this area6.
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antibody levels to various mycobacterial species
by ELISA in serum samples from a group of
children and young individuals belonging to the
south Indian BCG trial area and from a group
of young British subjects to obtain information
on the sensitisation patterns to mycobacterial
antigens in these three groups to find out if there
is any association between antibody levels and
tuberculin reactivity status in children belonging
to this area, and to compare the changes, if any,
and the differences in changes in the antibody
levels after BCG vaccination in young individuals
belonging to this area and Britain.
Material and Methods
Serum samples : Serum samples collected
from 36 children from Koppur village in the
south Indian BCG trial area were used. The age
of these children ranged from 2 to 6 years and
the mean was 4.4 years. The tuberculin reactivity
to PPD-S ranged from 0 to 30mm and the mean
was 7.5mm. The children could be divided into
three different tuberculin reactivity groups; 18
had 0-3mm reactivity, 8 had 4-10mm reactivity
and 10 had >10mm reactivity, representing low,
intermediate and high level of reactivity to
PPD-S.
Serum samples, collected before as well as 8
weeks after BCG vaccination and tuberculin
conversion,from 13 youngindividuals from
Trivellore in the same geographic area (mean age
16.5 yrs) and 20 young British subjects (mean
age, 14.5 yrs) were also included in the present
study. The pre-BCG Mantoux reaction to
PPD-S was <8mm to 3TU in the young Indians
and <4mm to 4TU in the young British subjects.
The post-BCG/tuberculin conversion reaction was
>12 mm to 1 TU in these individuals.
Serum samples from the young British subjects
were provided by D.B. Lowrie, National Institute
of Medical Research, Mill Hill, London.
Antigens : The IgG antibody levels in the
serum samples were estimated by ELISA against
PPD-RT 22 and mycobacterial sonicate supernatant
antigens listed in Tables 1 and 2.
Paramasivan in the Royal Postgraduate Medical
School, London, as described earlier10. PPD-RT
22 was obtained from the BCG Laboratory,
Madras.
ELISA procedure : ELISA to estimate the
antimycobacterial antibodies of class IgG in the
serum samples was done as described by Narayanan
et al11. Briefly, ‘antigen coating of microwell plates
(Gibco/Nunc Cat. No. 439454) was carried out
using 0.1ml of 5mcg/ml solution of the antigen in
carbonate buffer (0.06M, pH 9.6) per well. Each
serum sample was divided into two aliquots and
given different code numbers. Each coded serum
sample was tested at 1/40 and 1/80 dilutions on
15 plates, each plate coated with a different
mycobacterial antigen. A 1/100 dilution of anti-
human IgG peroxidase conjugale (Sigma Cat. No.
A-6029) was used as the secondary antibody and
orthophenylene diamine (OPD) was used as the
substrate. The optical density (OD) of the resultant
reaction in each well was read at 490nm in a Biotek
ELISA plate reader.
Statistical analysis: From the OD values from
duplicate samples tested, average values were
calculated for each dilution of the serum. The
mean antibody levels against individual antigens
for the different tuberculin reactivity groups
among the children were compared by unpaired
t-test. Mean antibody levels against individual
antigens for the pre- and post-vaccination samples
were compared by paired t-test. A one-way
ANOVA was carried out for all the antigens in
the three tuberculin reactivity groups, and the
means were tested for increasing trend after
adjusting for the antigens as covariant.
Results
The mean IgG antibody levels in OD units at
1/40 dilutions of serum samples from the 36
Koppur children belonging to the three different
tuberculin reactivity groups are presented in
Table 1. Antibody levels were highest against
M.scrofulaceum and M.avium serotype 8 while
the lowest levels were against M.tuberculosis
H37Rv in all the three groups. The ranking of
antibody levels (from highest to lowest) was also
similar in these three groups: it was M.scrofulaceum
followed by M.avium intracelluare serotype 8,
Serum samples from children (meanage 4.4 years) belonging to different tuberculin reactivity groups
Antigen
Tuberculin reactivity M t b  M t b Mtb Mbo BCG Mkan MscrMai Mai Mter Mfla Mgor Mfor Mche PPD
Group mean din. H37Rv 51 7219 8 16
0-3mm 0.33 Mean .128 .284 .222 .175 .216 .199 .488 .386 .218 .234 .200 .218 .230 .232 .234(n=18) SD  .050 .127 .096 .069 .091 .070 .133 .069 .045 .068 .036 .040 .042 .042 .044
p<.001
4-10mm 8.62 Mean .138 .265 .220 .172 .194 .194 .425 .370 .217 .225 .184 201 .218 .222 .222
(n=8) SD  .059 .159 .110 .076 .079 .088 .153 .091 .038 .078 .026 .027 .033 .038 .035
p<.001
>10mm 19.5 Mean .150 .300 .251 .186 .227 .201 .476 .358 .215 .259 .189 .202 .204 .223 .218
(n=10) SD  .068 .172 .105 .095 .106 .096 .135 .084 .061 .050 .038 .044 .027 .038 .024
All Children Mean .136 .284 .229 .177 .214 .198 .471 .375 .217 .239  .193   .210 .220 .227 .227
(n=36) SD  .056 .144 .100 .076 .091 .079 .137 .077 .047 .065 .035 .039 .037 .040 .038
Mtb H37Rv = M.tuberculosis H37Rv (laboratory strain), Mtb 51 = M.tuberculosis 51 (British strain), Mtb 7219 = M.tuberculosis 7219 (South
Indian strain), Mbo = M.bovis (NCTC 5693), BCG = M.bovis BCG (Glaxo), Mkan= M. Kansasii (NCTC 10268) Mscr = M. Scrofulaceum
(NCTC 10803) Mai8 = M. avium intracellulare serotype 8 (NCTC 10610), Mai16 =M.avium intracellulare s rotype 16 (NCTC 10425),
Mter = M. terrae (NCTC 10856), Mfla = M.flavescens (NCTC 10271), Mgor= M.gordonae (NCTC 10267). Mfor = M.fortuitum (NCTC
10394), Mche =M.chelonei (NCTC 10882), PPD = PPD RT22.
BCG Antigen*
status Mtb Mtb Mtb Mbo BCG Mkan Mscr MaiMai Mter Mfla Mgor Mfor Mche PPD
H37Rv 51 7219 8 16
Pre- Mean .320 .378 .346









.342 .348 .368 .306
.076 .088 .052 .108
.323 .361 .375 .301
.052 .085 .053 .074
.245 .273 .456 .408 .396 .260
.058 .067 .094.094 .102 .082
.236 .262 .454.405 .401 .265
.055 .044 .087 .079 .095 .074
POST Mean .321 .379 .340
BCG SD .029 .034 .120
Young British Subjects (n=20)
PRE- Mean .334 .262 .483 .302 .432 .283 .296 .374 .434 .406 .358 .437 .360 .447 .442
BCG SD .090 .075 .112 .065 .083 .083 .076 .053.077 .079 .060 .070 .071 .100 .095
p<.01 p<.01
POST-   Mean .343 .267 .510 .397 .429 .290 .315 .375.449 .417  .394 .465.364 .429 .406
BCG SD .087 .075 .107 .052 .084 .068 .076 .052.082 .076 .080 .073 .061 .095 .076
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M. tuberculosis 51, M.terrae. PPD-RT 22,
M.chelonei, M.fortuitum, M.tuberculosis 7219,
M.avium intracellulare serotype 16, M.gordonae,
BCG, M.flavescens. M.kansasii, M.bovis and
M.tuberculosis H37Rv in the 0-3mm group; the
same pattern with only the positions of
M.tuberculosis 7219 and M.fortuitum, and
M.kansasii and M.flavescens interchanged in the
4-10mm group; and, again, a similar pattern with
M.tuberculosis 7219 and BCG moving up in the
order and the positions of M.chelonei. PPD-RT
22, M.fortuitum and M.gordonae changed in the
>10mm group. Similar results were obtained with
1/80 dilutions of the serum samples (data not
presented). The mean tuberculin reactivity in the
three groups of children were 0.33, 8.62 and
19.5mm. Unpaired t-test showed that there were
no significant differences in the mean antibody
levels against individual antigens between the
three tuberculin reactivity groups (p>0.05). In
one-way ANOVA, no significant variation was
seen, and there was no statistically significant
increasing trend.
Of the Koppur children, 23 were male and 12
were female. The mean tuberculin reactivities in
the male and female children were 6.70 and
9.08mm. respectively. The difference in the
tuberculin reactivities of the two groups was not
Statistically significant (p>0.05). The differences
between the males and females in the mean
antibody levels against individual mycobacterial
antigens were also not statistically significant
(p>0.05).
The pattern of antibody levels at 1/40 dilution
of serum samples from the young individuals
from Trivellore were different from those in the
Koppur children (Table 2). In the pre-BCG young
individuals from Trivellore, the antibody levels
were highest against M. bovis BCG and
M.gordonae. The lowest levels at this dilution
were seen against PPD-RT22 and M.terrae. At
1/80 dilution also, similar results were obtained
(data not presented). In the young Indian subjects,
the mean antibody levels against individual antigens
in post-BCG; serum samples were similar to the
levels in pre-BCG samples; the order of antibody
levels to the 15 antigens was also the same in
post-BCG samplesxcept that M.flavescens and
PPD-RT22 had interchanged their positions. Results
with 1/80 dilutions (data not shown) were very
little different from those with 1/40 dilutions.
Paired t-test revealed that none of the differences
in the mean antibody levels against individual
antigens between the pre- and post-BCG serum
samples at 1/40 or 1/80 dilution was statistically
significant (p>0.05).
The pattern of antibody levels was different
in the young British subjects. The highest levels
of antibodies at 1/40 dilution of both pre- and
post-BCG/tuberculin conversion serum samples
were found against M. uberculosis 7219. The
lowes  levels were seen against M.kansasii and
M.tub rculosis 51. Essentially, identical patterns
were obtained with 1/80 dilutions of the serum
samples also (data not shown).
In the young British subjects, the post-BCG
serum samples had significantly higher mean 
antibody levels than pre-BCG samples against
M.tuberculosis 7219, M.flavescens and M.gordonae
at 1/40 dilution (Table 2) and to M.gordonae
(.282 and .313 in the pre-and post-BCG samples.
respectively) at 1/80 dilution also (p<0.05). The
mea  antibody levels against the other antigens.
indivi ually,were similar (differences not
statistically significant, p>0.05) in the pre-and
post-BCG samples.
Discussion
Even though the sample size is perhaps too
small to permit generalization, several interesting
observations are evident from this study. It has
been reported earlier that M.avium intracellulare
and M.scrofulaceum are among the NTM species
most frequently isolated from the sputum of
s bjects belonging to the south Indian BCG trial
area6. The prominence of antibody response to
M.avium intracellulare nd M.scrofulaceum in
subjects from this area in the present study also
suggests that these NTM species are most likely
o b  the ones responsible for the early appearance
and wide prevalence of DTH to PPD-B in this
area.
The pattern of antimycobacterial antibodies in
the young individuals (mean age 16.5 yrs) from
Trivellore was different from that in the Koppur
children (mean age 3.4 years). Age, along with
any differences in the profile of environmental
mycobacteria, could probably account for the
difference in the patterns of antibody levels
between the two groups of subjects.
An interesting observation in the present study
was the relatively low levels of antibodies seen
against the antigens to which the older subjects
were likely to have had more exposure as in the
case of M.tuberculosis 7219 (prepared from a
south Indian low virulence strain) and
M.tuberculosis 51 (prepared from a British strain)
in the Indian and British subjects, respectively.
The present study showed that in the Koppur
children there were no significant differences in
the mean antibody levels against individual antigens
including PPD-RT 22 between the three tuberculin
reactivity groups (0-3,3-10 and >10mm) indicating
that tuberculin reactivity may be independent of
the antimycobacterial antibody levels in these
children. Many earlier studies by others have
examined the relationship between tuberculin
reactivity status and antimycobacterial antibody
levels with similar findings12-15. Correlation between
tuberculin reactivity and antibody levels have
also been reported by others16-17.
The relationship between BCG vaccination
and antibody levels has been examined by many
workers. Raheman et al13 in India did not find
any correlation. Some of the studies conducted
abroad have also reported similar findings15,17,20.
On the other hand, positive correlation between
BCG vaccination status and antibody levels have
been reported by others21-24. Based on such
evidence from literature, it has been concluded
by Grange7 that BCG vaccination appeared to
induce only a transient antibody response.
The differences seen in the present study
between the Indian and British subjects in the
humoral immune response to BCG vaccination
could be due to the differences in the pre-existing
sensitisation patterns between these two
groups4,5. Prior contact with shared mycobacterial
antigens could accelerate subsequent responses to
these antigens and may also suppress the formation
of antibodies to newly introduced specific antigens
by the phenomenon of antigenic competition7.
Genetic differences between the two groups
studied could also be involved acting through the
HLA class 2 immune response genes25.
The differences in the patterns of antibodies
observed in the present study between the Indian
and British subjects could be due to differences
in the degree of exposure and in the mycobacterial
antigens encountered by these two groups5.
According to Grange7, differences in antibody
levels between individuals could be due to
differences in prior exposure of antigens different
a tigens being processed differently by
macrophages, the amount of antigens, local tissue
reactions to the antigens, formation of immune
complex, general state of nutrition, interaction of
other immune responses, presence of
immunosuppressive factors and genetic factors.
The relevance of the differences seen between
the British subjects and Indian subjects from the
BCG trial area in the humoral immune response
to BCG vaccination and pattern of antibodies is
not clear. Stanford et al26 examined the value of
multiple skin testing. lymphocyte transformation
test and ELISA of antibodies to mycobacterial
antigens as correlates of protection. Of the three
types of tests assessed, only skin testing appeared
to be of any value as a measure of protection.
The question whether the differences in the
antibody patterns and response to BCG vaccination
in the Indian and British subjects seen in the
present study have any such prognostic significance
needs to be addressed further.
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